Profil
Andrew Obenshain currently works at Inventiva SA, as Chief Executive Officer & Director from 2025, bluebird bio (UK) Ltd., as Director from 2017, and Biotechnology Innovation Organization, as Director.
Mr. Obenshain also formerly worked at bluebird bio, Inc., as President, Chief Executive Officer & Director from 2021 to 2025 and Shire Pharmaceuticals, Inc., as General Manager-France & Benelux from 2015 to 2016.
Mr. Obenshain received his undergraduate degree from Dartmouth College and Masters Business Admin degree from Kellogg School of Management.
Postes actifs de Andrew Obenshain
| Sociétés | Poste | Début |
|---|---|---|
| INVENTIVA | Directeur Général | 01/10/2025 |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Directeur/Membre du Conseil | 30/03/2017 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrew Obenshain
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Directeur Général | 02/06/2025 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/09/2016 |
Formation de Andrew Obenshain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
















